Romatoid Artrit Hastasında Metotreksat Toksisitesi

Cush JJ. Rheumatoid Arthritis: Early Diagnosis and Treatment. Rheum Dis Clin North Am. 2022;48(2):537-547

Akdağ H, Kırmusaoğlu S. Romatoid artrit tedavisinde uygulanan güncel yaklaşımlar. Haliç Üniversitesi Fen Bilimleri Dergisi. 2019;2(2):197-206.

Yurdakul S. Long actıng drugs. Turkiye Klinikleri Journal of Internal Medical Sciences. 2006;2(25):52-59.

van Ede AE, Laan RF, Blom HJ, De Abreu RA, van de Putte LB. Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Semin Arthritis Rheum. 1998;27(5):277-292.

Gilani ST, Khan DA, Khan FA, Ahmed M. Adverse effects of low dose methotrexate in rheumatoid arthritis patients. J Coll Physicians Surg Pak. 2012;22(2):101-104.

Prasad P, Verma S, Surbhi, Ganguly NK, Chaturvedi V, Mittal SA. Rheumatoid arthritis: advances in treatment strategies. Mol Cell Biochem. 2023;478(1):69-88.

Savran Y, Akkoç N. Romatoid Artrit Tedavisi. Dahili Tıp Bilimleri Dergisi. 2005;12(4):167-174.

Strober BE, Menon K. Folate supplementation during methotrexate therapy for patients with psoriasis. J Am Acad Dermatol. 2005;53(4):652-659.

Brown PM, Pratt AG, Isaacs JD. Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers. Nat Rev Rheumatol. 2016;12(12):731-742.

Arslan E, Özçelik F, Çakar M, Öztosun M, Demirbaş Ş, Sağlam K. Düşük doz oral metotreksat kullanımı ile ortaya çıkan pansitopeni ve deliryum tablosu: olgu sunumu. Gülhane Tıp Dergisi. 2014;56(3):182-184.

Yélamos O, Català A, Vilarrasa E, Roé E, Puig L. Acute severe methotrexate toxicity in patients with psoriasis: a case series and discussion. Dermatology. 2014;229(4):306-309.

Güneysu, F, Sarıtaş A, Durmuş E, Güneysu S. Metotreksat kullanıma bağlı pansitopeni. Eurasian Journal of Toxicology. 2020;2(3):76-77.

Demirel A, Kırnap M. Romatoid artrit tedavisinde geleneksel ve güncel yaklaşımlar. Sağlık Bilimleri Dergisi. 2010;19(1):74-84.

Schmiegelow K, Müller K, Mogensen SS, et al. Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy. F1000Res. 2017;6:444. Published 2017 Apr 7.

Romão VC, Lima A, Bernardes M, Canhão H, Fonseca JE. Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity?. Immunol Res. 2014;60(2-3):289-310.

Oğuz, Y, Eyilete T. Methotrexate-induced pancytopenia in two patients with renal dysfunction. Turkısh Nephrology Dıalysıs And Transplantatıon Journal. 2011;20(1):93-95.

Kremer JM, Maini RN, Romain PL. Major side effects of low-dose methotrexate. UpToDate. Accessed date: 1 March 2009;53:17-21.

Nast A, Boehncke WH, Mrowietz U, et al. S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update. J Dtsch Dermatol Ges. 2012;10 Suppl 2:S1-S95.

Yoon KH, Ng SC. Early onset methotrexate-induced pancytopenia and response to G-CSF: a report of two cases. J Clin Rheumatol. 2001;7(1):17-20.

Kessels RP. Patients' memory for medical information. J R Soc Med. 2003;96(5):219-222.